Molecular and cellular mechanisms of pneumococcal meningitis

Annals of the New York Academy of Sciences

Volumn 797, Issue , 1996, Pages 42-52

  Tuomanen, Elaine I ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOCONJUGATE; TEICHOIC ACID; THROMBOCYTE ACTIVATING FACTOR RECEPTOR;

ACUTE PHASE RESPONSE; BACTERIAL CELL WALL; BACTERIAL MENINGITIS; BACTERIUM ADHERENCE; BLOOD BRAIN BARRIER; CELL INTERACTION; CEREBROSPINAL FLUID; CONFERENCE PAPER; HOST PARASITE INTERACTION; HUMAN; NONHUMAN; STREPTOCOCCUS PNEUMONIAE; SUBARACHNOID SPACE;

BACTERIA (MICROORGANISMS); STREPTOCOCCUS PNEUMONIAE;

EID: 0030450506     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1996.tb52948.x     Document Type: Conference Paper

References (66)

1. STEVENSON, B., J. SILICIANO, M. MOOSEKER & D. GOODENOUGH. 1986. Identification of ZO-1: A high molecular weight polypeptide associated with the tight junction in a variety of epithelia. J. Cell Biol. 103: 755-766.
2. JESAITIS, L. & G. DA. 1994. Molecular characterization and tissue distribution of ZO-2, a tight junction protein homologous to ZO-1 and the Drosophila discs-large tumor suppressor protein. J. Cell Biol. 124: 949-961.
3. FURUSE, M., T. HIRASE, M. ITOH, A. NAGAFUCHI, S. YONEMURA, S. TSUKITA & S. TSUKITA. 1993. Occludin: A novel integral membrane prein localizing at tight junctions. J. Cell Biol. 123: 1777-1788.
4. SCHLOSSBAUER, B. 1993. The blood brain barrier: Morphology molecules, and neurothelin. BioEssays 15: 341-346.
5. SCHLOSSBAUER, B. & K.-H. HERZOG. 1990. Neurothelin: An inducible cell surface glycoprotein of blood brain barrier specific endothelial cells and distinct neurons. J. Cell Biol. 110: 1261-1274.
6. LEVINE, S. 1987. Choroid plexus: Target for systemic disease and pathway to the brain. Lab. Invest. 56: 231-233.
7. DERMIETZEL, R. & D. KRAUSE. 1991. Molecular anatomy of the blood brain barrier as defined by immunocytochemistry. Int. Rev. Cytol. 127: 57-109.
8. TUOMANEN, E. 1996. Entry of pathogens into the central nervous system. FEMS Micro. Revs. 18: 289-299.
9. DAUM, R., D. SCHEIFELE, V. SYRIOPOULOU, D. AVERILL & A. SMITH. 1978. Ventricular involvement in experimental Haemophilus influenzae meningitis. J. Pediatr. 93: 927-930.
10. CUNDELL, D. & E. TUOMANEN. 1994. Receptor specificity of adherence of Streptococcus pneumoniae to human type II pneumocytes and vascular endothelial cells in vitro. Microbiol. Pathog. 17: 361-374.
11. KRIVAN, H. C., D. D. ROBERTS & V. GINSBURG. 1988. Many pulmonary pathogenic bacteria bind specifically to the carbohydrate sequence GalNacB1-4Gal found in some glycolipids. Proc. Natl. Acad. Sci. USA 85: 6157-6161.
12. HAMBURGER, M. & O. ROBERTSON. 1940. Studies of the pathogenesis of experimental pneumococcus pneumonia in the dog. J. Exp. Med. 72: 261-274.
13. CUNDELL, D., N. GERARD, C. GERARD, I. IDANPAAN-HEIKKILA & E. TUOMANEN. 1995. Streptococcus pneumoniae anchors to activated eukaryotic cells by the receptor for platelet activating factor. Nature. 377: 435-438.
14. LASKY, L. A. 1992. Selectins: Interpreters of cell-specific carbohydrate information. Science 258: 964-969.
15. ZIMMERMAN, G., S. PRESCOTT & T. MCINTYRE. 1992. Endothelial cell interactions with granulocytes: Tethering and signaling molecules. Immunol. Today 13: 93-100.
16. WISSNER, A., R. SCHAUB, P. SUM, C. KOHLER & B. GOLDSTEIN. 1986. Analogues of platelet activating factor: Some modifications of the phosphorylcholine moiety. J. Med. Chem. 29: 328-333.
17. CHAO, W. & M. OLSON. 1993. Platelet-activating factor: Receptors and signal transduction. Biochem. J. 292: 617-622.
18. GENG, J., K. MOORE, A. JOHNSON & R. MCEVER. 1991. Neutrophil recognition requires a Ca-induced conformational change in the lectin domain of GMP-140. J. Biol. Chem. 266: 22313-22318.
19. HONDA, Z.-I., M. NAKAMURA, I. MIKI, M. MINAMI, T. WATANABE, Y. SEYAMA, H. OKADO, H. TOH, K. IOT, T. MIYAMOTO & T. SHIMIZU. 1991. Cloning by functional expression of platelet activating factor receptor from guinea pig lung. Nature 349: 342-346.
20. KUNZ, D., N. GERARD & C. GERARD. 1992. The human leukocyte platelet activating factor receptor. J. Biol. Chem. 267: 9101-9106.
21. GERARD, N. & C. GERARD. 1994. Receptor-dependent internalization of platelet-activating factor. J. Immunol. 152: 793-800.
22. GEELEN, S., C. BATTACHARYYA & E. TUOMANEN. 1993. Cell wall mediates pneumococcal attachment and cytopathology to human endothelial cells. Infect. Immun. 61: 1538-1543.
23. SPELLERBERG, B., S. PRASAD, C. CABELLOS, M. BURROUGHS, P. CAHILL & E. TUOMANEN. 1995. Penetration of the blood brain barrier: Enhancement of drug delivery and imaging by bacterial glycopeptides. J. Exp. Med. 182: 1-8.
24. SAMPSON, J., R. O'CONNOR, A. STINSON, J. THARPE & H. RUSSELL. 1994. Cloning and nucleotide sequence analysis of psaA, the Streptococcus pneumoniae gene encoding a 37-kilodalton protein homologous to previously reported Streptococcus sp. adhesins. Infect. Immun. 62: 319-324.
25. PEARCE, B., Y. YIN & H. MASURE. 1993. Genetic identification of exported proteins in Streptococcus pneumoniae. Mol. Microbiol. 9: 1037-1050.
26. WEISER, J., R. AUSTRIAN, P. SREENIVASAN & H. MASURE. 1994. Phase variation in pneumococcal opacity: Relationship between colonial morphology and nasopharyngeal colonization. Infect. Immun. 62: 2582-2589.
27. SALUGA, S. & J. WEISER. 1995. The genetic basis of colonial opacity in Streptococcus pneumoniae: Evidence for the effect of box elements on phenotypic variation. Mol. Microbiol 16: 215-227.
28. CUNDELL, D., J. WEISER, J. SHEN, A. YOUNG & E. TUOMANEN. 1995. Relationship between colonial morphology and adherence of Streptococcus pneumoniae. Infect. Immun. 63: 757-761.
29. SPELLERBERG, D., J. SANDROS, D. CUNDELL, B. PEARCE & H. MASURE. 1996. Pyruvate oxidase as a determinant for virulence of Streptococcus pneumoniae. Mol. Microb. 19: 803-813.
30. CUNDELL, D., B. PEARCE, J. SANDROS, A. NAUGHTON & H. MASURE. 1995. Peptide permeases from Streptococcus pneumoniae affect adherence to eucaryotic cells. Infect. Immun. 63: 2493-2498.
31. BIRKNESS, K., B. SWISHER, E. WHITE, E. LONG, E. EWING & F. QUINN. 1995. A tissue culture bilayer model to study the passage of Neisseria meningitidis. Infect. Immun. 63: 402-409.
32. VAN DER FLIER, M., N. CHHUN, T. WIZEMANN, J. MIN, J. MCCARTHY & E. TUOMANEN. 1995. Adherence of Streptococcus pneumoniae to immobilized fibronectin. Infect. Immun. 63: 4317-4322.
33. TUOMANEN, E. I., A. TOMASZ, B. HENGSTLER & O. ZAK. 1985. The relative role of bacterial cell wall and capsule in the induction of inflammation in pneumococcal meningitis. J. Infect. Dis. 151: 535-540.
34. TUOMANEN, E., H. LIU, B. HENGSTLER, O. ZAK & A. TOMASZ. 1985. The induction of meningeal inflammation by components of the pneumococcal cell wall. J. Infect. Dis. 151: 859-868.
35. TUOMANEN, E., R. RICH & O. ZAK. 1987. Induction of pulmonary inflammation by components of the pneumococcal cell surface. Am. Rev. Respir. Dis. 135: 869-874.
36. RIPLEY-PETZOLDT, M. L., G. S. GIEBINK, S. K. JUHN, D. AEPPLI, A. TOMASZ & E. TUOMANEN. 1988. The contribution of pneumococcal cell wall to the pathogenesis of experimental otitis media. J. Infect. Dis. 157: 245-255.
37. TUOMANEN, E., H. POLLACK, A. PARKINSON, M. DAVIDSON, R. FACKLAM, R. RICH & O. ZAK. 1988. Microbiological and clinical significance of a new property of defective lysis in clinical strains of pneumococci. J. Infect. Dis. 158: 36-43.
38. GARCIA-BUSTOS, J. & A. TOMASZ. 1990. A biological price of antibiotic resistance: Major changes in the peptidoglycan structure of penicillin-resistant pneumococci. Proc. Natl. Acad. Sci. USA 87: 5415-5419.
39. JENNINGS, H., C. LUGOWSKI & N. YOUNG. 1980. Structure of the complex polysaccharide C-substance from Streptococcus pneumoniae. Biochemistry 19: 4712-4719.
40. TOMASZ, A. 1967. Choline in the cell wall of a bacterium: Novel type of polymer-linked choline in pneumococcus. Science 157: 694-697.
41. WINKELSTEIN, J. & A. TOMASZ. 1978. Activation of the alternative complement pathway by pneumococcal cell wall teichoic acid. J. Immunol. 120: 174-178.
42. GEELEN, S., C. BHATTACHARYYA & E. TUOMANEN. 1992. Induction of procoagulant activity on human endothelial cells by Streptococcus pneumoniae. Infect. Immun. 60: 4179-4183.
43. TUOMANEN, E. & S. SANDE. 1989. Inhibition of the binding of penicillin to the pneumococcal penicillin binding proteins (PBPs) by exogenous cell wall peptides. J. Gen. Microbiol. 135: 639-642.
44. RIESENFELD-ORN, I., S. WOLPE, J. F. GARCIA-BUSTOS, M. K. HOFFMAN & E. TUOMANEN. 1989. Production of interleukin-1 but not tumor necrosis factor by human monocytes stimulated with pneumococcal cell surface components. Infect. Immun. 57: 1890-1893.
45. HEUMANN, D., C. BARRAS, A. SEVERIN, M. GLAUSER & A. TOMASZ. 1994. Gram positive cell walls stimulate synthesis of tumor necrosis factor alpha and interleukin-6 by human monocytes. Infect. Immun. 62: 2715-2721.
46. CABELLOS, C., D. E. MACINTYRE, M. FORREST, M. BURROUGHS, S. PRASAD & E. TUOMANEN. 1992. Differing roles of platelet-activating factor during inflammation of the lung and subarachnoid space. J. Clin. Invest. 90: 612-618.
47. PUGIN, J., D. HEUMANN, A. TOMASZ, V. KRAVCHENKI, Y. AKAMATSU, M. NISHIJIMA, M. LAUSER, P. TOBIAS & R. ULEVITCH. 1994. CD14 is a pattern recognition receptor. Immunity 1: 509-516.
48. TOMASZ, A. & K. SAUKKONEN. 1989. The nature of cell wall-derived inflammatory components of pneumococci. Pediatr. Infect. Dis. J. 8: 902-903.
49. SPELLERBERG, B. & E. TUOMANEN. 1994. The pathophysiology of pneumococcal meningitis. Ann. Med. 26: 411-418.
50. TUOMANEN, E., K. SAUKKONEN, S. SANDE, C. CIOFFE & S. D. WRIGHT. 1989. Reduction of inflammation, tissue damage, and mortality in bacterial meningitis in rabbits treated with monoclonal antibodies against adhesion-promoting receptors of leukocytes. J. Exp. Med. 170: 959-969.
51. TAN, T., C. SMITH, E. HAWKINS, E. MASON & S. KAPLAN. 1995. Hematogenous bacterial meningitis in an ICAM-1 deficient infant mouse model. J. Infect. Dis. 171: 342-349.
52. PFEFFER, K., T. MATSUYAMA, T. KUNDIG & T. MAK. 1993. Mice deficient for the 55kD tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenese infection. Cell 73: 457-467.
53. SHA, W., H. LIOU, E. TUOMANEN & D. BALTIMORE. 1995. Targeted disruption of the p50 subunit of NF-kB leads to multifocal defects in immune responses. Cell 80: 321-330.
54. BURROUGHS, M., E. ROZDZINSKI, S. GEELEN & E. TUOMANEN. 1993. A structure-activity relationship for induction of meningeal inflammation by muramyl peptides. J. Clin. Invest. 92: 297-302.
55. KRUEGER, J., D. DAVENNE, J. WALTER, S. SHOHAM, S. KUBILLUS, R. ROSENTHAL, S. MARTIN & K. BIEMANN. 1987. Bacterial peptidoglycans as modulators of sleep. Brain Res. 403: 258-266.
56. HEISS, L., J. LANCASTER, J. CORBETT & W. GOLDMAN. 1994. Epithelial autotoxicity of nitric oxide: Role in the respiratory cytopathology of pertussis. Proc. Natl. Acad. Sci. USA 91: 267-270.
57. GUERRA-ROMERO, L., J. TUREEN, M. FOURNIER, V. TAKRIDES & M. TAUBER. 1993. Amino acids in cerebrospinal and brain interstitial fluid in experimental pneumococcal meningitis. Pediatr. Res. 33: 510-513.
58. TAUBER, M., M. SACHDEVA, S. KENNEDY, H. LOETSCHER & W. LESSLAUER. 1992. Toxicity in neuronal cells caused by cerebrospinal fluid from pneumococcal and gram negative meningitis. J. Infect. Dis. 166: 1045-1050.
59. PATON, J. C., R. A. LOCK, C. J. LEE, J. P. LI, A. M. BERRY, T. J. MITCHELL, P. W. ANDREW, D. HANSMAN & G. J. BOULNOIS. 1991. Purification and immunogenicity of genetically obtained pneumolysin toxoids and their conjugation to Streptococcus pneumoniae type 19F polysaccharide. Infect. Immun. 59: 2297-2304.
60. BOULNOIS, G. J., J. C. PATON, T. J. MITCHELL & P. W. ANDREW. 1991. Structure and function of pneumolysin, the multifunctional, thiol-activated toxin of Streptococcus pneumoniae. Mol. Microbiol. 5: 2611-2616.
61. RUBINS, J. B., P. G. DUANE, D. CLAWSON, D. CHARBONEAU, J. YOUNG & D. E. NIEWOEHNER. 1993. Toxicity of pneumolysin to pulmonary alveolar epithelial cells. Infect. Immun. 61: 1352-1358.
62. FRIEDLAND, I., M. PARIS, S. HICKEY, S. SHELTON, K. OLSEN, J. PATON & G. MCCRACKEN. 1995. Limited role of pneumolysin in the pathogenesis of pneumococcal meningitis. J. Infect. Dis. 172: 805-809.
63. BHATT, S., A. LAURETANO, C. H. CABELLOS, R. LEVINE, W. Hsu, J. NADOL & E. TUOMANEN. 1993. The progression of hearing loss in experimental pneumococcal meningitis: Correlation with cerebrospinal fluid cytochemistry. J. Infect. Dis. 167: 675-683.
64. BHATT, S., C. CABELLOS, I. J. NADO, C. HALPIN, A. LAURENTANO, W. XU & E. TUOMANEN. 1994. The impact of dexamethasone on hearing loss in experimental pneumococcal meningitis. Pediatr. Infect. Dis. J. 14: 93-96.
65. LEBEL, M. H., B. J. FREIJ, G. A. SYROGIANNOPOULOS ET AL. 1988. Dexamethasone therapy for bacterial meningitis. N. Engl. J. Med. 15: 964-971.
66. TUOMANEN, E., B. HENGSTLER, R. RICH, M. BRAY, O. ZAK & A. TOMASZ. 1987. Nonsteroidal anti-inflammatory agents in the therapy of experimental pneumococcal meningitis. J. Infect. Dis. 155: 985-990.